TABLE 1.
Demographic and clinical characteristics by treatment group (n = 43)
| GTR (n = 21) | PR+RT (n = 22) | p Value | |
|---|---|---|---|
| Sex |
|
|
0.364 |
| Male |
11 (52.4) |
8 (36.4) |
|
| Female |
10 (47.6) |
14 (63.6) |
|
| Shunted hydrocephalus |
|
|
0.001 |
| No |
19 (90.5) |
9 (40.9) |
|
| Yes |
2 (9.5) |
13 (59.1) |
|
| Recurrence |
|
|
>0.999 |
| No |
14 (66.7) |
15 (68.2) |
|
| Yes |
7 (33.3) |
7 (31.8) |
|
| Pituitary dysfunction |
20 (95.2) |
15 (68.2) |
0.046 |
| DI |
19 (90.5) |
12 (54.5) |
0.016 |
| Hypothalamic obesity |
14 (66.7) |
14 (63.6) |
>0.999 |
| Age at 1st posttreatment evaluation, yrs |
6.4 (2.2 to 16.8) |
8.5 (3.8 to 16.4) |
0.177 |
| Time from treatment to 1st posttreatment evaluation, yrs |
0.5 (−0.6 to 4.0) |
0.3 (−0.6 to 4.2) |
0.448 |
| Tumor vol, ml | 39.0 (0.7 to 164.5) | 22.2 (0.3 to 119.7) | 0.209 |
Values are presented as number (%) of patients or median (range) unless otherwise indicated.